4.7 Article

The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling

期刊

NATURE IMMUNOLOGY
卷 9, 期 9, 页码 1028-1036

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.1644

关键词

-

资金

  1. UK Medical Research Council
  2. Arthritis Research Campaign
  3. Novo Nordic Foundation
  4. Danish Research Agency
  5. Astra-Zeneca
  6. Boehringer-Ingelheim
  7. GlaxoSmithKline
  8. Merck
  9. Pfizer
  10. MRC [MC_U127081014] Funding Source: UKRI
  11. Medical Research Council [MC_U127081014] Funding Source: researchfish

向作者/读者索取更多资源

The kinases MSK1 and MSK2 are activated 'downstream' of the p38 and Erk1/2 mitogen-activated protein kinases. Here we found that MSK1 and MSK2 were needed to limit the production of proinflammatory cytokines in response to stimulation of primary macrophages with lipopolysaccharide. By inducing transcription of the mitogen-activated protein kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10, MSK1 and MSK2 exerted many negative feedback mechanisms. Deficiency in MSK1 and MSK2 prevented the binding of phosphorylated transcription factors CREB and ATF1 to the promoters of the genes encoding interleukin 10 and DUSP1. Mice doubly deficient in MSK1 and MSK2 were hypersensitive to lipopolysaccharide-induced endotoxic shock and showed prolonged inflammation in a model of toxic contact eczema induced by phorbol 12-myristate 13-acetate. Our results establish MSK1 and MSK2 as key components of negative feedback mechanisms needed to limit Toll-like receptor-driven inflammation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据